Genetic landscape of extreme responders with anaplastic oligodendroglioma. - Wikidata - awgldk - TriplyDB

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

http://www.wikidata.org/entity/Q33829209

about

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.

P2860

Q55114505-0425995E-F087-4A82-9BD2-E49A2F7BF187

P2860

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

http://www.wikidata.org/entity/Q33829209

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

@ast

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

@en

type

label

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

@ast

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

@en

prefLabel

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

@ast

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

@en

P1433

Q33829209-82B06164-BB43-404B-AE39-76DA20D3F829

P1476

Q33829209-CB2D538F-6C54-47DB-999A-6B310B4449E5

P2093

Q33829209-060A2014-99D8-487E-9ADD-8C7C5FCECB11

Q33829209-0EBB508D-C019-4ABE-A297-2BA52F81502B

Q33829209-15EB4F35-2EF1-488B-A3C1-39B02EAD9491

Q33829209-21F5F86C-B215-4C69-8806-6C960DB592AD

Q33829209-246F971E-02AF-4420-81A8-1EE520393C3F

Q33829209-250F1686-ED9D-41D7-9021-9B124D17B514

Q33829209-2E0E5307-EB3E-4326-80CD-8FA6BECBD89B

Q33829209-36E1AD9D-E0C3-4F2C-BD99-A71D619BC08B

Q33829209-4581B0D4-C9FF-435D-87FC-933B9F94CCE4

Q33829209-72749D13-A9F1-4057-BF52-5C8A7C84DC18

P2860

Q33829209-1A2742CA-6DBA-4AE8-A90A-F6F3678AC48B

Q33829209-1B48D343-8721-4EFC-8672-6B54761EECBB

Q33829209-2275C507-5648-4A3A-BAD9-5F28A27ABAAF

Q33829209-24CA701B-95C4-47EF-AF8D-B2C02FBC3686

Q33829209-355F39A3-FF6F-4CFD-A1E8-238570D16BD2

Q33829209-49136712-F01E-4CDA-9854-E8D92F97A3BC

Q33829209-5093C40C-DF1A-4241-9FC7-9B81973264D2

Q33829209-57269DCF-BAA8-4F0E-B571-08442FD36D03

Q33829209-62E1FAF2-A847-4BA5-AF9D-F9F39E78AA03

Q33829209-897E15D8-1229-4D75-A95C-7FD07043AF9A

P304

Q33829209-0C19F340-515C-4BA5-9CFE-FE3B6B7A9033

P31

Q33829209-53BE08AB-D99B-48D9-8991-CE6CB5218C7D

P356

Q33829209-DFF3A50E-4621-42D8-8327-9F136D4AE3A0

P407

Q33829209-EBB4B804-389A-4AA2-85B4-D59BB1F636F6

P433

Q33829209-533B608D-989F-4FD3-9C97-6C3081E39CA4

P478

Q33829209-AA894681-BA2D-47D4-90C3-A0D9D7515E35

P50

Q33829209-20539B5E-C3F7-47A2-BAA3-5006DDBCC9DB

Q33829209-9EE5DCFA-68BB-436C-9C82-1A6144AB7661

Q33829209-EB622CF3-5B2D-4583-AAED-FC6E12790FE6

P577

Q33829209-B8258CBE-12B8-4B2A-9E31-AAD6F6ED23D7

P698

Q33829209-3270402E-86ED-4196-A418-E04A928DC66A

P921

Q33829209-A74D613A-20DA-4A4C-8558-D56857D22BAE

P932

Q33829209-2571DF26-8E17-401B-8CC8-8D778784B75A

P356

ONCOTARGET.16773

P1433

P1476

Genetic landscape of extreme responders with anaplastic oligodendroglioma.

@en

P2093

Alan C Hartford

http://www.w3.org/2001/XMLSchema#string

Arnab Chakravarti

http://www.w3.org/2001/XMLSchema#string

Chetan Bettegowda

http://www.w3.org/2001/XMLSchema#string

Gregory J Cairncross

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Bahary

http://www.w3.org/2001/XMLSchema#string

Luis Souhami

http://www.w3.org/2001/XMLSchema#string

Matthias Holdhoff

http://www.w3.org/2001/XMLSchema#string

Minesh P Mehta

http://www.w3.org/2001/XMLSchema#string

Ming Zhang

http://www.w3.org/2001/XMLSchema#string

Nickolas Papadopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 and IDH2 mutations in gliomas

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

Esx1 is an X-chromosome-imprinted regulator of placental development and fetal growth

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Ca

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.

P304

35523-35531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16773

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth W Kinzler

Maria Werner-Wasik

Bert Vogelstein

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28388591

http://www.w3.org/2001/XMLSchema#string

P921

oligodendroglioma

P932

5482595

http://www.w3.org/2001/XMLSchema#string